Submission Details
| 510(k) Number | K211274 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 27, 2021 |
| Decision Date | January 10, 2022 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K211274 is an FDA 510(k) clearance for the iQ 2 Nasal Mask, Phantom 2 Nasal Mask, a Ventilator, Non-continuous (respirator) (Class II — Special Controls, product code BZD), submitted by Sleepnet Corporation (Hampton, US). The FDA issued a Cleared decision on January 10, 2022, 258 days after receiving the submission on April 27, 2021. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5905.
| 510(k) Number | K211274 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 27, 2021 |
| Decision Date | January 10, 2022 |
| Days to Decision | 258 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | BZD — Ventilator, Non-continuous (respirator) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5905 |